MAGNESIUM SULFATE ANHYDROUS

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

16 API Suppliers, 12 USDMF, 4 JDMF, 4 NDC API, 5 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

2 Drugs in Development

2 Drugs in Development

FINISHED DOSAGE FORMULATIONS

107 FDF Dossiers, 66 FDA Orange Book, 14 Europe, 8 Canada, 5 South Africa, 14 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

SOLUTION;INTRAMUSCULAR, INTRAVENOUS - 10GM/20ML (500MG/ML), SOLUTION;INTRAMUSCULAR, INTRAVENOUS - 1GM/2ML (500MG/ML), SOLUTION;INTRAMUSCULAR, INTRAVENOUS - 25GM/50ML (500MG/ML), SOLUTION;INTRAMUSCULAR, INTRAVENOUS - 5GM/10ML (500MG/ML), EMULSION;INTRAVENOUS - 2.4%;20MG/100ML;6.8GM/100ML;68MG/100ML;124MG/100ML;170MG/100ML;105MG/100ML;3.5GM/100ML (1440ML), EMULSION;INTRAVENOUS - 2.4%;20MG/100ML;6.8GM/100ML;68MG/100ML;124MG/100ML;170MG/100ML;105MG/100ML;3.5GM/100ML (1920ML), EMULSION;INTRAVENOUS - 2.4%;20MG/100ML;6.8GM/100ML;68MG/100ML;124MG/100ML;170MG/100ML ;105MG/100ML;3.5GM/100ML (2400ML), EMULSION;INTRAVENOUS - 3.3%;29MG/100ML;9.8GM/100ML;96MG/100ML;174MG/100ML;239MG/100ML ;147MG/100ML;3.9GM/100ML (1026ML), EMULSION;INTRAVENOUS - 3.3%;29MG/100ML;9.8GM/100ML;96MG/100ML;174MG/100ML;239MG/100ML;147MG/100ML;3.9GM/100ML (1540ML), EMULSION;INTRAVENOUS - 3.3%;29MG/100ML;9.8GM/100ML;96MG/100ML;174MG/100ML;239MG/100ML;147MG/100ML;3.9GM/100ML (2053ML), EMULSION;INTRAVENOUS - 3.3%;29MG/100ML;9.8GM/100ML;96MG/100ML;174MG/100ML;239MG/100ML;147MG/100ML;3.9GM/100ML (2566ML), POWDER;ORAL - 1.6GM/BOT;3.13GM/BOT;17.5GM/BOT, TABLET;ORAL - 0.225GM;0.188GM;1.479GM

RELATED EXCIPIENT COMPANIES

1 Rochem International Inc, 1 SPI Pharma, 7 DKSH, 1 Pharm-RX Chemical, 3 Faran Shimi Pharmaceutical, 3 Boai NKY Pharmaceuticals Ltd, 7 Gangwal Healthcare, 3 Nanjing Well Pharmaceutical, 1 Pfanstiehl, 4 ACG Worldwide, 8 Actylis, 4 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 3 BASF, 1 Bioplus Life Sciences, 1 BioSpectra, 10 Corel Pharma Chem, 2 DFE Pharma, 3 Finar, 10 Gangwal Chemicals, 5 Ideal Cures Pvt Ltd, 17 Kerry, 3 Kima Chemical, 6 Lonza Capsugel, 11 Microlex e.U, 1 Nanjing Bold Chemical, 1 Novo Excipients, 1 Pharmatrans-Sanaq, 5 Pluviaendo, 2 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 2 Qualicaps, 11 Roquette, 12 Seppic, 3 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 8 Sigachi Industries, 2 The Dow Chemical Company, 2 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

45 Coating Systems & Additives, 32 Fillers, Diluents & Binders, 22 Controlled & Modified Release, 20 Thickeners and Stabilizers, 18 Parenteral, 18 Direct Compression, 14 Co-Processed Excipients, 13 Solubilizers, 11 Lubricants & Glidants, 10 Film Formers & Plasticizers, 9 Empty Capsules, 9 Granulation, 8 Emulsifying Agents, 8 Taste Masking, 6 Disintegrants & Superdisintegrants, 5 Topical, 5 API Stability Enhancers, 4 Vegetarian Capsules, 4 Coloring Agents, 3 Rheology Modifiers, 3 Chewable & Orodispersible Aids, 2 Surfactant & Foaming Agents

DIGITAL CONTENT

1 DATA COMPILATION #PharmaFlow, 45 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

2 US Medicaid Prescriptions, 10 Finished Drug Prices

MARKET PLACE

16 APIs, 6 FDF Dossiers, 1 EXCIPIENTS

PATENTS & EXCLUSIVITIES

4 US Patents, 1 US Exclusivities

REF. STANDARDS & IMPURITIES

1 USP, 1 Others

$ Xls

Filters

Xls

USFDA APPLICATION NUMBER - 19316 / DOSAGE - SOLUTION;INTRAMUSCULAR, INTRAVENOUS - 5GM/10ML (500MG/ML)

Ingredient Name	Basis of Strength	Strength
Active Ingredient/Active Moiety
MAGNESIUM SULFATE HEPTAHYDRATE(UNII: SK47B8698T) (MAGNESIUM CATION - UNII:T6V3LHY838)	MAGNESIUM SULFATE HEPTAHYDRATE	500mg in 1

Inactive Ingredients

Ingredient Name	Cardinal Health	HF Acquisition Co. LLC, DBA Health First	Medical Purchasing Solutions, LLC	REMEDYREPACK INC.	X-GEN Pharmaceuticals, Inc.
SODIUM HYDROXIDE(55X04QC32I)
SULFURIC ACID(O40UQP6WCF)
WATER(059QF0KO0R)

Drug Product Composition: MAGNESIUM SULFATE ANHYDROUS